Robin L Carhart-Harris Selected Research

Hallucinogens (Psychedelics)

5/2022	Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
1/2022	Psychedelics and health behaviour change.
3/2020	Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
1/2019	Psychedelics as a treatment for disorders of consciousness.
10/2017	The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
1/2017	Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
4/2016	Neural correlates of the LSD experience revealed by multimodal neuroimaging.
1/2016	Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
11/2013	Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin L Carhart-Harris Research Topics

Disease

8	Treatment-Resistant Depressive Disorder 01/2020 - 07/2008
2	Schizophrenia (Dementia Praecox) 11/2018 - 02/2015
2	Alcoholism (Alcohol Abuse) 10/2017 - 07/2016
2	Psychotic Disorders (Schizoaffective Disorder) 01/2016 - 11/2013
1	Mental Disorders (Mental Disorder) 05/2022
1	Feeding and Eating Disorders (Eating Disorder) 01/2022
1	Anorexia Nervosa 01/2021
1	Neuroinflammatory Diseases 03/2020
1	Alzheimer Disease (Alzheimer's Disease) 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2020
1	Consciousness Disorders 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2017
1	Mood Disorders (Mood Disorder) 10/2017
1	Nausea 07/2016
1	Death (Near-Death Experience) 07/2016
1	Confusion (Bewilderment) 07/2016
1	Headache (Headaches) 07/2016
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2016
1	Hallucinations (Hallucination) 04/2016

Drug/Important Bio-Agent (IBA)

10	Psilocybin (Psilocibin)IBA 01/2021 - 11/2013
9	Hallucinogens (Psychedelics)IBA 05/2022 - 11/2013
3	Pharmaceutical PreparationsIBA 07/2016 - 11/2013
2	Lysergic Acid Diethylamide (LSD)IBA 03/2020 - 10/2017
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Ketamine FDA LinkGeneric 11/2018
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 10/2017
1	CannabinoidsIBA 02/2015
1	gamma-Aminobutyric Acid (GABA)IBA 02/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2015
1	Cholinergic Agents (Cholinergics)IBA 02/2015
1	Opioid Analgesics (Opioids)IBA 02/2015

Therapy/Procedure

1	Aftercare (After-Treatment) 10/2017
1	Deep Brain Stimulation 07/2008